Budget 2024: Healthcare industry leaders demand increase in allocation, emphasise on strengthening infra
Asthma inhaler price cap in US may help pharma companies to secure more loyal customer base: GlobalData
‘Predicting the exact nature of future pandemics is challenging; Focus should be on vigilance and preparedness’
FE Mental Health Series | ‘Therapy is expensive and finding the right therapist is even more challenging’
FE Mental Health Series | ‘Therapy is expensive and finding the right therapist is even more challenging’
FE Mental Health Series | How apps are changing consultation landscape amid drought of experts in India
FE Mental Health Series: ‘Three layoffs, divorce, and no support from my family pushed me into depression’
FE Mental Health Series | ‘I lost my very close friend to Postpartum Depression, her death still haunts me’
FE Mental Health Series | You are just sad not depressed; Stop using serious mental health disorders as adjectives
FE Mental Health Series | Beyond spring fans, metal frames—India needs to save its students from suicide epidemic urgently
Our primary goal is to double our revenue, enter higher-margin niche segments and increase footprint: Dr. Saloni Wagh, Director, Supriya Lifescience Ltd. By Sushmita Panda
We are working on reviving its R&D strengths; To launch new products 1-2 months: Rajnish Rohatgi, CEO, Orchid Pharma By Sushmita Panda
There is a lack of awareness among couples regarding fertility treatments: Abhishek Aggrawal, CBO, Birla Fertility and IVF, C.K Birla Group By Sushmita Panda
We are moving into newer disease areas; Xenpozyme will be launched in India soon: Anil Raina, GM, Sanofi Specialty Care, India By Sushmita Panda
‘Lack of awareness, delayed diagnosis remain challenges in accessing timely treatment of breast cancer’
Metropolis Healthcare expands its footprint in Africa; Inaugurates Regional Reference Laboratory in Nairobi
We will focus on entering into untapped cities, wellness segment and explore acquisition opportunities: Surendran Chemmenkotil, CEO, Metropolis Healthcare
Lifesciences companies expect more than one-fifth of revenue from connected health in next 5 years: Capgemini report
Boy with severe epilepsy becomes world’s first patient to get ‘skull device’—Here’s what you need to know
